Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

MedImmune and Pasteur Merieux Connaught develop second-generation Lyme disease vaccine

Dec. 3, 1998

CPMP issues positive opinion for E.U. approval of Zenapax

Dec. 2, 1998

U.S. patent issued for Maxim's MaxVax technology

Dec. 2, 1998

Abbott purchases additional La Jolla stock

Dec. 1, 1998

OraVax files IND for colitis vaccine

Nov. 30, 1998

North American Vaccine continues product launch of Certiva in U.S.

Nov. 26, 1998

Positive clinical data supports Siga's unique vaccine delivery system

Nov. 25, 1998

Chiron reports phase II results of novel Meningococcus C vaccine trial

Nov. 24, 1998

Thalidomide analogue CC-3052 is more active, less toxic than parent drug

Nov. 23, 1998

Phase II data demonstrate efficacy of Avant's rotavirus vaccine

Nov. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...